MetLife, Inc. (NYSE:MET) Shares Sold by Glenmede Trust Co. NA

Glenmede Trust Co. NA cut its holdings in MetLife, Inc. (NYSE:METGet Rating) by 9.3% during the third quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 294,732 shares of the financial services provider’s stock after selling 30,055 shares during the period. Glenmede Trust Co. NA’s holdings in MetLife were worth $17,913,000 as of its most recent SEC filing.

Other hedge funds and other institutional investors also recently bought and sold shares of the company. Financial Advocates Investment Management grew its holdings in shares of MetLife by 3.9% during the third quarter. Financial Advocates Investment Management now owns 3,697 shares of the financial services provider’s stock worth $224,000 after purchasing an additional 138 shares during the last quarter. 9258 Wealth Management LLC grew its holdings in shares of MetLife by 1.8% during the third quarter. 9258 Wealth Management LLC now owns 8,292 shares of the financial services provider’s stock worth $504,000 after purchasing an additional 150 shares during the last quarter. Kaizen Financial Strategies grew its holdings in shares of MetLife by 1.4% during the third quarter. Kaizen Financial Strategies now owns 10,800 shares of the financial services provider’s stock worth $656,000 after purchasing an additional 153 shares during the last quarter. Parkside Financial Bank & Trust grew its holdings in shares of MetLife by 5.7% during the third quarter. Parkside Financial Bank & Trust now owns 2,971 shares of the financial services provider’s stock worth $181,000 after purchasing an additional 160 shares during the last quarter. Finally, Carolinas Wealth Consulting LLC grew its holdings in shares of MetLife by 26.4% during the first quarter. Carolinas Wealth Consulting LLC now owns 767 shares of the financial services provider’s stock worth $54,000 after purchasing an additional 160 shares during the last quarter. 88.15% of the stock is currently owned by institutional investors and hedge funds.

Analysts Set New Price Targets

Several brokerages have issued reports on MET. JPMorgan Chase & Co. raised their price objective on MetLife from $77.00 to $80.00 and gave the stock an “overweight” rating in a report on Friday, January 6th. Citigroup raised their price target on MetLife from $77.00 to $84.00 in a report on Wednesday, November 16th. StockNews.com initiated coverage on MetLife in a report on Wednesday, October 12th. They set a “hold” rating on the stock. The Goldman Sachs Group lowered MetLife from a “buy” rating to a “neutral” rating and lowered their price target for the stock from $80.00 to $78.00 in a report on Monday, January 9th. Finally, Morgan Stanley raised their price target on MetLife from $87.00 to $88.00 and gave the stock an “overweight” rating in a report on Tuesday, January 10th. Four research analysts have rated the stock with a hold rating and nine have issued a buy rating to the company’s stock. According to data from MarketBeat.com, MetLife has a consensus rating of “Moderate Buy” and a consensus price target of $80.18.

Insider Buying and Selling

In related news, EVP Steven J. Goulart sold 29,401 shares of MetLife stock in a transaction that occurred on Monday, December 12th. The stock was sold at an average price of $71.88, for a total transaction of $2,113,343.88. Following the completion of the transaction, the executive vice president now directly owns 273,310 shares in the company, valued at approximately $19,645,522.80. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. In other MetLife news, EVP Bill Pappas sold 5,000 shares of the business’s stock in a transaction on Wednesday, December 7th. The shares were sold at an average price of $75.55, for a total value of $377,750.00. Following the transaction, the executive vice president now owns 65,147 shares in the company, valued at approximately $4,921,855.85. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Also, EVP Steven J. Goulart sold 29,401 shares of the company’s stock in a transaction dated Monday, December 12th. The shares were sold at an average price of $71.88, for a total transaction of $2,113,343.88. Following the completion of the sale, the executive vice president now owns 273,310 shares in the company, valued at approximately $19,645,522.80. The disclosure for this sale can be found here. Insiders sold 37,401 shares of company stock worth $2,706,824 in the last ninety days. Insiders own 0.26% of the company’s stock.

MetLife Stock Performance

MET traded down $0.44 during trading on Wednesday, reaching $70.53. The company’s stock had a trading volume of 437,012 shares, compared to its average volume of 3,559,995. The company’s fifty day moving average price is $73.23 and its 200-day moving average price is $68.44. MetLife, Inc. has a 52-week low of $57.41 and a 52-week high of $77.36. The company has a debt-to-equity ratio of 0.60, a quick ratio of 0.14 and a current ratio of 0.14. The company has a market capitalization of $55.34 billion, a price-to-earnings ratio of 26.68, a price-to-earnings-growth ratio of 2.14 and a beta of 1.07.

MetLife (NYSE:METGet Rating) last posted its quarterly earnings results on Wednesday, November 2nd. The financial services provider reported $1.21 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.18 by $0.03. MetLife had a net margin of 3.26% and a return on equity of 13.60%. The company had revenue of $23.69 billion during the quarter, compared to the consensus estimate of $19.89 billion. On average, equities analysts forecast that MetLife, Inc. will post 7.04 earnings per share for the current fiscal year.

MetLife Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Tuesday, March 14th. Investors of record on Tuesday, February 7th will be given a dividend of $0.50 per share. The ex-dividend date of this dividend is Monday, February 6th. This represents a $2.00 annualized dividend and a dividend yield of 2.84%. MetLife’s dividend payout ratio is currently 75.19%.

MetLife Profile

(Get Rating)

MetLife, Inc, a financial services company, provides insurance, annuities, employee benefits, and asset management services worldwide. It operates through five segments: U.S.; Asia; Latin America; Europe, the Middle East and Africa; and MetLife Holdings. The company offers life, dental, group short-and long-term disability, individual disability, pet insurance, accidental death and dismemberment, vision, and accident and health coverages, as well as prepaid legal plans; administrative services-only arrangements to employers; and general and separate account, and synthetic guaranteed interest contracts, as well as private floating rate funding agreements.

Recommended Stories

Institutional Ownership by Quarter for MetLife (NYSE:MET)

Receive News & Ratings for MetLife Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MetLife and related companies with MarketBeat.com's FREE daily email newsletter.